Here’s a question. If a sector has a positive operating matrix, will you decide against buying stocks of companies from the ...

Looking to build long-term wealth? Explore five high-performing mid cap mutual funds suited for SIP investors targeting ...

From trade deal-related uncertainties to a not-so-great Q1 earnings season, there are many headwinds for businesses at this ...

Written by Robin Brown at The Motley Fool Canada Mid-cap stocks are a nice place to look when an investor wants modest risk and attractive rewards. Mid-cap stocks are typically classified as those ...

RBI MPC's decision to not cut rates impacted some of the rate sensitive stocks, while no further enhancement to liquidity ...

On July 1, Alan McKnight, the CIO at Regions Wealth Management, appeared on CNBC to explain how his biggest worry is ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them ...

Its market cap is at $3.6 billion, and despite already racking up a couple of key approvals, this stock has been struggling for multiple months. Last year, it declined by 37%.

With a market cap of $5.6 billion, it’s one of the most impressive biotech performers of 2025, with shares up 38% year-to-date. The stock is trading just 7% below its all-time high, which was ...

In the stock market, the term "mid-cap" is defined by companies with a medium-sized market cap, typically between $2 billion and $10 billion. Mid-cap stocks are often companies that have moved ...

Mid-cap stocks are typically classified as those that have a market cap ranging between $1 billion and $10 billion. Generally, these are already established businesses with an established record.